88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy WUXI, China , June 30, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ... 2026-06-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026 SAN DIEGO , June 30, 2026 /PRNewswire/ -- At BIO 2026, EirGenix presented its comprehensive HER2-positive breast cancer biosimilar portfolio and highlighted its integrated one-stop contract development ... 2026-06-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China SAN FRANCISCO and SUZHOU, China , June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ... 2026-06-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Xellar Raises $50 Million Series A Financing to Build the Future of 3D Bio Intelligence Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery ... 2026-06-30T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board Deepening Its Commitment to Kidney Disease and Accelerating Toward Becoming a Global Leader in Renal Innovation ... 2026-06-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ever Supreme Launches Phase IIa Clinical Trial for CAR001, Accelerating Global Market Expansion TAICHUNG , June 29, 2026 /PRNewswire/ -- Ever Supreme Bio Technology Co., Ltd. (TWSE: 6712) announced on June 28 that CAR001, its proprietarily developed, allogeneic, "off-the-shelf" CAR-T ... 2026-06-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland , ... 2026-06-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia SHANGHAI , June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-06-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NextRise 2026, Seoul Successfully Wraps Up as Asia's Leading Startup Fair Co-hosted by KITA and KDB SEOUL, South Korea , June 26, 2026 /PRNewswire/ -- The Korea International Trade Association (KITA) and Korea Development Bank (KDB) successfully wrapped up NextRise 2026, Seoul, Asia's leading startup ... 2026-06-26T Biotechnology Computer/Electronics Health Care/Hospital Trade show news
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b trial of RC220 in combination with osimertinib for EGFR-mutant non-small cell lung cancer. The study will assess safety, pharmacokinetics, ... 2026-06-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved